Boston Partners lessened its holdings in Clarivate PLC (NYSE:CLVT - Free Report) by 96.8% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 139,566 shares of the company's stock after selling 4,227,785 shares during the quarter. Boston Partners' holdings in Clarivate were worth $548,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors have also added to or reduced their stakes in CLVT. Millstone Evans Group LLC raised its holdings in shares of Clarivate by 156.6% in the 1st quarter. Millstone Evans Group LLC now owns 7,545 shares of the company's stock valued at $30,000 after acquiring an additional 4,605 shares in the last quarter. Bessemer Group Inc. bought a new position in Clarivate during the 1st quarter worth approximately $30,000. Schonfeld Strategic Advisors LLC bought a new stake in shares of Clarivate in the 4th quarter worth approximately $56,000. MQS Management LLC bought a new stake in shares of Clarivate during the first quarter valued at approximately $44,000. Finally, Essex Financial Services Inc. bought a new stake in shares of Clarivate during the first quarter valued at approximately $45,000. Hedge funds and other institutional investors own 85.72% of the company's stock.
Insider Activity at Clarivate
In other news, insider James Gordon Samson sold 100,000 shares of the company's stock in a transaction that occurred on Tuesday, July 1st. The stock was sold at an average price of $4.53, for a total value of $453,000.00. Following the completion of the sale, the insider directly owned 1,271,103 shares in the company, valued at $5,758,096.59. This represents a 7.29% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 23.18% of the stock is owned by insiders.
Analyst Upgrades and Downgrades
CLVT has been the subject of several recent analyst reports. Jefferies Financial Group initiated coverage on Clarivate in a research note on Friday, July 18th. They issued a "hold" rating and a $4.50 price target for the company. Wall Street Zen cut Clarivate from a "buy" rating to a "hold" rating in a research report on Saturday, June 21st. Three investment analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Clarivate has a consensus rating of "Reduce" and an average price target of $4.83.
Get Our Latest Report on CLVT
Clarivate Stock Up 2.4%
Shares of NYSE:CLVT traded up $0.1050 on Friday, reaching $4.5050. The company had a trading volume of 3,229,573 shares, compared to its average volume of 5,612,731. Clarivate PLC has a 52-week low of $3.04 and a 52-week high of $7.15. The firm's 50 day simple moving average is $4.22 and its 200-day simple moving average is $4.19. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.90. The firm has a market capitalization of $3.03 billion, a PE ratio of -7.27 and a beta of 1.40.
Clarivate (NYSE:CLVT - Get Free Report) last posted its quarterly earnings results on Wednesday, July 30th. The company reported $0.18 earnings per share for the quarter, meeting the consensus estimate of $0.18. Clarivate had a positive return on equity of 8.65% and a negative net margin of 17.33%.The business had revenue of $621.40 million for the quarter, compared to the consensus estimate of $587.17 million. During the same quarter in the previous year, the business earned $0.20 EPS. The company's quarterly revenue was down 4.4% compared to the same quarter last year. Clarivate has set its FY 2025 guidance at 0.600-0.700 EPS. As a group, analysts expect that Clarivate PLC will post 0.63 earnings per share for the current fiscal year.
About Clarivate
(
Free Report)
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.
Featured Stories
Before you consider Clarivate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clarivate wasn't on the list.
While Clarivate currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access